Let Your Rabid Leftist Friends And Family Go
The Holiday Survival Guide (Trump WON Edition)
New York Democrat Issues Warning to His Party About Hochul
A Quick Bible Study Vol. 243: What the New Testament Says About Fearing...
Avoiding Self-Inflicted Trade and Economic Wounds
Democrats Ramp Up Their Criticism of Tulsi Gabbard
Why We Should Be Concerned Over the Philippine VP’s Comments
These Democratic Senators Could Sure Be in Trouble After Voting for Sanders' Anti-Israel...
Top Democrat Leader Obliterates The View’s Reasoning for Why Trump Won
Joe Rogan, Elon Musk Hilariously Spark Exchange On X Over Failing MSNBC
Matt Gaetz for Florida Governor?
Trump to Create New Position to Deal With Ukraine
Giving Thanks Is Good For You
The Hidden Pro-Life Message You Missed at Miss Universe
The Border's Broken Vetting System: Why We Can't Wait to Fix It
OPINION

Stocks in the News: Priceline Rises as Short Positions Grow

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
Advertisement
Advertisement
Advertisement

Stocks in the News is produced by Ransom Notes Radio and Goodfellow, LLC. Crista Huff manages Goodfellow LLC, a website that recommends outperforming stocks using fundamental and technical analysis. 

Advertisement

Stock number one is: 

DaVita HealthCare Partners Inc., (SYMBOL: DVA) and the headline says:

Rebasing Continues a String of Negative Surprises for DaVita – Citi Research

Medicare announced that reimbursement rates for dialysis may fall significantly in 2014, alarming investors in DaVita HealthCare, the largest U.S. dialysis provider.  “Monday’s announced Medicare cut for dialysis services far surpasses our worst fears,” reports Citi Research.  Buy-side analysts were expecting an approximate 2% cut, but the net cut proposal came in at 9.4%.

Watch for DaVita's earnings estimates to fall towards a no-growth scenario in 2014.

Berkshire Hathaway owns 14% of DaVita stock, causing recent speculation of a buyout offer, which may provide some ongoing support for the stock price.  The chart is bearish, with support at $115.

Our Ransom Note trendline says:  STAY ON THE SIDELINES.

DVA Chart

DVA data by YCharts

Stock number two is: 

Apple Inc., (SYMBOL: AAPL) and the headline says:

Tech Stocks Signaling Sustained U.S. Growth -- Bloomberg

“Shares of technology companies are rallying as investors see capital spending for their products strengthening along with the economy,” reports Bloomberg.

Apple shares are rallying with news that the company filed with the Japan Patent Office in June to trademark the term "iWatch". The company is believed to be developing a digital wristwatch, which could provide new growth opportunities.

Advertisement

Apple’s earnings estimates are holding steady; projected to fall 10% this year.  With a PE of 10.3 and a dividend yield of 2.98%, there’s limited downside at this point.  The trading range is firming up between $385 and $465.

Our Ransom Note trendline says: APPLE IS A TRADING BUY UNDER $420.

AAPL Chart

AAPL data by YCharts

Stock number three is:

Priceline.com Inc., (SYMBOL: PCLN) and the headline says:

Priceline.com Becomes #26 Most Shorted Nasdaq 100 Component -- Forbes

Online travel company Priceline.com has been seeing increased recent short action.  Given its bullish chart, investors should expect any near-term breakout to be enhanced by short-covering.

Priceline recently issued $1 billion in senior notes at low interest rates, and intends to repurchase $1 billion in stock.  Earnings are projected to grow 21-23 percent per year over the next three years.

In February and May, we told investors to buy shares in Priceline.  The stock is up 21% since our first recommendation, and appears immediately ready to break past upside resistance at $845.

Our Ransom Note trendline says: BUY PRICELINE.COM

PCLN Chart

PCLN data by YCharts

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos